Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day
Completed
Mylan Pharmaceuticals
Phase 1
2003-08-01
The primary objective of this study was to compare the adhesive quality of a new formulation
of the Mylan Estradiol Transdermal System with that of Climara® Transdermal System following
a single system application in 80 healthy postmenopausal female volunteers. As a secondary
objective, primary dermal irritation was assessed after removal of each transdermal system.
The study will examine the effects of estrogen and progesterone on the development of
atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the
menopausal transition.
Albert Einstein College of Medicine of Yeshiva University
Phase 4
2005-09-01
The study will examine the effects of estrogen and progesterone on the development of
atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the
menopausal transition.
The study will examine the effects of estrogen and progesterone on the development of
atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the
menopausal transition.
The study will examine the effects of estrogen and progesterone on the development of
atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the
menopausal transition.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
